
Alicia Morgans, MD, discusses ARACOG findings on cognitive outcomes with darolutamide vs enzalutamide and the influence of genetic dementia risk.
In this video, Justin Chee, MD, discusses the takeaways and further research of 2 studies he presented at the 2021 International Continence Society Meeting: “The Optilume urethral drug coated balloon for recurrent anterior urethral strictures: 3-year results from the ROBUST I Study,” and “A randomized controlled trial evaluating the Optilume urethral drug coated balloon vs endoscopic management for treatment of recurrent anterior urethral strictures.” Chee is a reconstructive urological surgeon at Murac Health, East Melbourne, Australia.






